Clinical Trial Update: APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF [Phase 4]

View source ↗

Summary

Phase 4 trial comparing apixaban versus phenprocoumon in patients with acute coronary syndrome and atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Syndrome

Drugs mentioned

• Apixaban (apixaban)
• Phenprocoumon (phenprocoumon)

Snippet

Sponsor: LMU Klinikum | Conditions: Acute Coronary Syndrome, Atrial Fibrillation | Phase 4 | Status: COMPLETED